Johnson & Johnson plans to file for FDA approval of a nasal spray formula called esketamine this year. On Saturday, they presented new research suggesting the drug worked well alongside a traditional antidepressant for a month.
Read More About This Article: https://ift.tt/2IewbtM
No comments :
Post a Comment